COMMUNIQUÉS West-GlobeNewswire

CONVOCATION À L’ASSEMBLÉE GÉNÉRALE ORDINAIRE 2026 DE IBA SA
11/05/2026
CONVOCATION À L’ASSEMBLÉE GÉNÉRALE ORDINAIRE 2026 DE IBA SA – MERCREDI 10 JUIN 2026, À 10H00 – Cher Actionnaire, Nous avons l’honneur de vous convoquer à l’Assemblée générale ordinaire (l’«  AGO  ») d’IBA, qui se [...]
Solésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™
11/05/2026
New platform technologies enable OTC-grade sensitive skin claims in previously inaccessible anhydrous formats and bring environmental protection deeper into the color cosmetics assortment ROMEOVILLE, Ill., May 11, 2026 [...]
MindBio Develops Fatigue Prediction Model using Speech Analytics and AI
11/05/2026
Patent application filed in World First claims. Detection of Neurologically Active Substances and Fatigue in a Human by Analysis of Voice Characteristics. Early warning technologies for the detection of neurologically [...]
NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in May
11/05/2026
NAARDEN, the Netherlands and MIAMI, May 11, 2026 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, [...]
Disc Medicine to Participate in Upcoming Investor Conferences
11/05/2026
WATERTOWN, Mass., May 11, 2026 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for [...]
FibroBiologics Advancing Development of a Fibroblast Treatment for Hantavirus
11/05/2026
Will Apply Existing Preclinical Findings in Reducing Severe Immune-Mediated Lung Failure to Potential Emerging Global Crisis HOUSTON, May 11, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics [...]
CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities
11/05/2026
AUSTIN, Texas, May 11, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage : The human brain remains one of the most protected, and difficult to treat, organs in the body. At the center of this challenge is the blood [...]
Fate Therapeutics Showcases FT819 Clinical Activity in SLE without the use of Conditioning Chemotherapy at the 2026 ASGCT Annual Meeting
11/05/2026
Single dose treatment of FT819 without conditioning chemotherapy achieves lupus low disease activity state (LLDAS) in active SLE Patients; durable B cell remodeling is exhibited by depletion of major B cell clones up to [...]
The Future of Intoxication Detection May Be in Your Voice
11/05/2026
AUSTIN, Texas, May 11, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage : The ability to accurately detect drug and alcohol intoxication has long been a persistent challenge across industries, from law enforcement [...]
The Next Generation of the GLP-1 Revolution Is Already Underway
11/05/2026
AUSTIN, Texas, May 11, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage : Obesity and type 2 diabetes mellitus (T2DM) have become two of the most pressing healthcare challenges worldwide, driving rising rates of [...]
Cruise Ship Virus Outbreaks Highlight Massive Emerging Demand for TOMI Environmental Solutions’ SteraMist Technology
11/05/2026
Rising Norovirus, Hantavirus, and Pandemic-Era Infection Fears Could Create a Multi-Billion-Dollar Opportunity Across Cruise Ships, Hotels, Hospitals, Airports and Commercial Facilities FREDERICK, Md., May 11, 2026 ( [...]
Adial Pharmaceuticals Reports 2026 First Quarter Financial Results and Provides Business Update
11/05/2026
GLEN ALLEN, Va., May 11, 2026 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and [...]
Abeona Therapeutics® Announces Activation of Children's Hospital of Philadelphia as a New Qualified Treatment Center for ZEVASKYN®
11/05/2026
CLEVELAND, May 11, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing genetic medicines for serious diseases with high unmet need, today announced [...]
Cellectar Biosciences to Report First Quarter Financial Results and Host a Conference Call on Thursday, May 14, 2026
11/05/2026
FLORHAM PARK, N.J., May 11, 2026 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of [...]
Reunion Neuroscience to Present Full Data from RECONNECT Phase 2 Clinical Trial at Upcoming ASCP and APA Annual Meetings
11/05/2026
MORRISTOWN, N.J., May 11, 2026 (GLOBE NEWSWIRE) -- Reunion Neuroscience, Inc., a clinical-stage biopharmaceutical company committed to revolutionizing the treatment of underserved mental health disorders through the [...]
Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™
11/05/2026
Addition of the power liposuction capability as a second advanced liposuction modality is expected to drive even greater market demand for AYON CLEARWATER Fla., May 11, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation [...]
Assembly Biosciences to Present at the BofA Securities 2026 Global Health Care Conference
11/05/2026
SOUTH SAN FRANCISCO, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced that [...]
AGC Biologics Joins Orphan Therapeutics Accelerator’s Clinical Development Network as a Manufacturing Partner to Advance Cell and Gene Therapies for Ultra-Rare Diseases
11/05/2026
Collaboration brings AGC Biologics’ advanced therapy expertise and global footprint to OTXL’s network, supporting a sustainable path from clinical development to commercial access for therapies serving the smallest [...]
Exagen Inc. Reports First Quarter 2026 Results
11/05/2026
Delivers record total revenue and AVISE(R) CTD average selling price CARLSBAD, Calif., May 11, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported [...]

Pages